175 related articles for article (PubMed ID: 33618555)
1. Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.
Oldenburg J; Malinverno M; Globisch MA; Maderna C; Corada M; Orsenigo F; Conze LL; Rorsman C; Sundell V; Arce M; Smith RO; Yau ACY; Billström GH; Mägi CÖ; Beznoussenko GV; Mironov AA; Fernando D; Daniel G; Olivari D; Fumagalli F; Lampugnani MG; Dejana E; Magnusson PU
Stroke; 2021 Apr; 52(4):1418-1427. PubMed ID: 33618555
[TBL] [Abstract][Full Text] [Related]
2. CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway.
Choi JP; Yang X; He S; Song R; Xu ZR; Foley M; Wong JJ; Xu CR; Zheng X
Stroke; 2021 Apr; 52(4):1428-1436. PubMed ID: 33657857
[TBL] [Abstract][Full Text] [Related]
3. Novel Chronic Mouse Model of Cerebral Cavernous Malformations.
Cardoso C; Arnould M; De Luca C; Otten C; Abdelilah-Seyfried S; Heredia A; Leutenegger AL; Schwaninger M; Tournier-Lasserve E; Boulday G
Stroke; 2020 Apr; 51(4):1272-1278. PubMed ID: 31992178
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell clonal expansion in the development of cerebral cavernous malformations.
Malinverno M; Maderna C; Abu Taha A; Corada M; Orsenigo F; Valentino M; Pisati F; Fusco C; Graziano P; Giannotta M; Yu QC; Zeng YA; Lampugnani MG; Magnusson PU; Dejana E
Nat Commun; 2019 Jun; 10(1):2761. PubMed ID: 31235698
[TBL] [Abstract][Full Text] [Related]
5. B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
Shi C; Shenkar R; Zeineddine HA; Girard R; Fam MD; Austin C; Moore T; Lightle R; Zhang L; Wu M; Cao Y; Gunel M; Louvi A; Rorrer A; Gallione C; Marchuk DA; Awad IA
J Neuroimmune Pharmacol; 2016 Jun; 11(2):369-77. PubMed ID: 27086141
[TBL] [Abstract][Full Text] [Related]
6. Cervicothoracic spinal epidural cavernous hemangioma: case report and review of the literature.
Minh NH
Surg Neurol; 2005 Jul; 64(1):83-5; discussion 85. PubMed ID: 15993196
[TBL] [Abstract][Full Text] [Related]
7. Widespread cerebral cavernous haemangiomata found after 24 years of intermittent symptoms.
Turner MR; Macleod WN
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):404. PubMed ID: 11181870
[No Abstract] [Full Text] [Related]
8. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
9. T2*-weighted MR images of a patient with familial cerebral cavernous malformation.
Maeda K; Terashima T; Kawai H; Sanada M
Intern Med; 2007; 46(8):541-2. PubMed ID: 17443056
[No Abstract] [Full Text] [Related]
10. [Histopathology of central nervous system cavernomas].
Mosnier JF; Brunon J; Nuti C
Neurochirurgie; 2007 Jun; 53(2-3 Pt 2):131-5. PubMed ID: 17498756
[TBL] [Abstract][Full Text] [Related]
11. Giant cerebral cavernous hemangiomas: a report of two cases and review of the literature.
Jhawar S; Nadkarni T; Goel A
Turk Neurosurg; 2012; 22(2):226-32. PubMed ID: 22437298
[TBL] [Abstract][Full Text] [Related]
12. Letter by Filippidis et al regarding article, "Evaluating strategies for the treatment of cerebral cavernous malformations".
Filippidis AS; Fountas KN; Kalani MY; Zabramski JM; Spetzler RF
Stroke; 2011 May; 42(5):e373. PubMed ID: 21393598
[No Abstract] [Full Text] [Related]
13. Measurement of Endothelial Barrier Function in Mouse Models of Cerebral Cavernous Malformations Using Intravital Microscopy.
Glading AJ
Methods Mol Biol; 2020; 2152():387-400. PubMed ID: 32524567
[TBL] [Abstract][Full Text] [Related]
14. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
15. Familial cerebral cavernous malformation.
Dziedzic T; Kunert P; Matyja E; Ziora-Jakutowicz K; Sidoti A; Marchel A
Folia Neuropathol; 2012; 50(2):152-8. PubMed ID: 22773461
[TBL] [Abstract][Full Text] [Related]
16. Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage.
Zabramski JM; Kalani MYS; Filippidis AS; Spetzler RF
World Neurosurg; 2016 Apr; 88():631-639. PubMed ID: 26578351
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Endothelial-to-Mesenchymal Transition to the Pathogenesis of Human Cerebral and Orbital Cavernous Malformations.
Takada S; Hojo M; Tanigaki K; Miyamoto S
Neurosurgery; 2017 Jul; 81(1):176-183. PubMed ID: 28368503
[TBL] [Abstract][Full Text] [Related]
18. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.
Gibson CC; Zhu W; Davis CT; Bowman-Kirigin JA; Chan AC; Ling J; Walker AE; Goitre L; Delle Monache S; Retta SF; Shiu YT; Grossmann AH; Thomas KR; Donato AJ; Lesniewski LA; Whitehead KJ; Li DY
Circulation; 2015 Jan; 131(3):289-99. PubMed ID: 25486933
[TBL] [Abstract][Full Text] [Related]
19. Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure.
Johnson AM; Roach JP; Hu A; Stamatovic SM; Zochowski MR; Keep RF; Andjelkovic AV
FASEB J; 2018 May; 32(5):2615-2629. PubMed ID: 29295866
[TBL] [Abstract][Full Text] [Related]
20. Giant intracranial cavernous haemangioma presented with enlarged head circumference in a child.
Li M; Li Y; Xu G; Mei J
J Paediatr Child Health; 2010 Dec; 46(12):788-9. PubMed ID: 21166918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
